ETSTOTCPharmaceutical PreparationsFiscal year ends March 31
Earth Science Tech, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.09+0.00 (+3.73%)
Close on Oct 19, 2026
- Market cap
- $25.57M
- P/E (TTM)
- 9.8
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2026
Gross margin
71.4%+43.1 pts over 5 years
Operating margin
–
Net margin
10.2%+3121.0 pts over 5 years
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +7.8% | +802.6% | +202.5% | – | |
| Gross profit | +4.9% | +949.3% | +263.9% | – | |
| Net income | +11.6% | – | – | – | |
| EPS, diluted | +9.1% | – | – | – | |
| Free cash flow | -67.3% | – | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | – | 149.8% | 66.9% | |
| Return on assets | – | -4000.8% | 45.3% | |
| Current ratio | – | 0.01 | 1.93 | |
| Debt to equity | – | – | – | |
| Net debt to EBITDA | – | – | – | |
| Interest coverage | – | -902.9× | – | |
| Inventory turnover | – | 2.4× | 17.2× | |
| Capex to revenue | – | – | 2.1% | |
| Diluted shares | – | – | 293M |
Cash use needs five years of cash flow figures
Earth Science Tech does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin10.2%
×Asset turnover4.45×
×Equity multiplier1.48×
=Return on equity, FY202666.9%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | 10.2% | 4.45× | 1.48× | 66.9% |
| FY2025 | 9.8% | 6.05× | 1.79× | 106.7% |
| FY2024 | 6.8% | 3.62× | 1.96× | 48.2% |
| FY2023 | -752.8% | 0.03× | -4.09× | 106.6% |
| FY2022 | 22468.7% | 0.20× | -0.02× | -92.9% |
| FY2021 | -3110.8% | 1.29× | -0.04× | 149.8% |
| FY2020 | -228.1% | 1.86× | -0.55× | 232.5% |
| FY2019 | -287.5% | 2.04× | -2.32× | 1356.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
4of 8 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero$3.63M
- Cash generatingOperating cash flow above zero$1.94M
- Return on assets improvedROA up on the prior year83.8% → 51.4%
- Earnings backed by cashOperating cash flow above net income$1.94M vs $3.63M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose0.99 → 1.93
- No dilutionShare count did not rise304M → 293M
- Gross margin improvedGross margin up on the prior year73.38% → 71.40%
- More efficientAsset turnover rose8.53 → 5.05